Fundz

Betaliq reported raising $6 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEJun 02, 2025

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale May 21, 2025)

Round Type

Seed

TampaBiotechnologyHealth CarePharmaceutical

Who else raised in Pharmaceutical and Biotechnology around the same time

Companies in the same sectors as Betaliq that raised within 45 days of this round, from Fundz verified event records.

  • Pelthos Therapeutics raised $50M on July 1, 2025.
  • Helus Pharma raised $50M on June 30, 2025.
  • USpharma Ltd raised an undisclosed amount (Private Equity) on June 30, 2025.
  • Biofrontera raised $11M on June 27, 2025.
  • Os Therapies raised $4.2M on June 23, 2025.
  • Shuttle Pharmaceutical Holdings raised $4.3M (Seed) on June 20, 2025.

Who to call at Betaliq, and when

A new round usually means Betaliq is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Betaliq raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Betaliq, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Betaliq. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Betaliq

Location

Tampa, Florida, United States

About

Betaliq is a clinical-stage private pharmaceutical company that focuses on developing treatments for glaucoma. The company has access to Eyesol®, a non-aqueous technology that addresses patient needs in eye care. They are actively engaged in negotiations for a merger with Eyenovia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Betaliq raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Betaliq's next move

See what Strategic adds

Betaliq raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.